Incontinentia pigmenti: Generation of an IKBKG deficient human iPSC line (KICRi002-A-1) on a 46,XY background using CRISPR/Cas9

Medicine and Dentistry

• Clustered Regularly Interspaced Short Palindromic Repeat 100%
• Cas9 100%
• Incontinentia pigmenti 100%
• Induced Pluripotent Stem Cell 100%
• In Vitro 33%
• Dysplasia 33%
• Drug Screening 33%
• Fetus Development 33%
• Loss of Function Mutation 33%
• Knock Out 33%
• Germ Layer 33%
• Karyotype 33%
• Messenger RNA 33%

Biochemistry, Genetics and Molecular Biology

• CRISPR/Cas9 100%
• Induced Pluripotent Stem Cell 100%
• IKBKG 100%
• Karyotype 20%
• Dysplasia 20%
• Drug Screening 20%
• Loss of Function Mutation 20%
• Fetus Development 20%
• Germ Layer 20%
• Messenger RNA 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Incontinentia pigmenti 100%
• Drug Screening 33%
• Dysplasia 33%
• Messenger RNA 33%